← Back to catalogue
Published

leukodystrophy

vr.tr.leukodystrophy · thing-q1821559

Let an agent explain leukodystrophies and their types and genetic basis in general terms, relay diagnosis, management and support information from health bodies and patient organisations, and route personal medical questions to clinicians.

Thing Registry Cross-cutting context XCT.STA
Bundle → Layer → Finding → QuestionsClassifiersWhat it isWhy it existsDistinguishing featuresWhat robots and AI may and may not doMoral aspectsOwnersLinks to other meta-modelsIdentity and identifiersDirect propertiesRecognitionCapabilities and actionsHazards and failure modesStandards and interfacesContext of useSources

Bundle → Layer → Finding → Questions Filled

4 bundles · 8 layers · 8 findings · 16 questions

Understand What leukodystrophies are.

Concept

Concept and types.

Concept

Concept.

  1. What are leukodystrophies, and how do hypomyelinating, demyelinating, adult-onset and vascular forms differ? definition
  2. Is the user asking about their own or a family member condition, which needs a clinician? boundary

Genetics

Genetics.

Genetics

Genetics.

  1. What genes and inheritance patterns underlie leukodystrophies? provenance
  2. Which entry fits a specific disorder? action
Manage Diagnosis and management.

Diagnosis

Diagnosis.

Diagnosis

Diagnosis.

  1. How are leukodystrophies diagnosed through imaging and genetic testing, in general terms? provenance
  2. Which entry fits brain imaging? action

Treatment

Treatment and care.

Treatment

Treatment.

  1. What treatments exist for specific forms, and what supportive care do guidelines describe? provenance
  2. Is the presentation free of unproven treatment claims? boundary
Family Families and screening.

Screening

Newborn screening.

Screening

Screening.

  1. Which leukodystrophies are included in newborn screening, and why does early detection matter? provenance
  2. Which entry fits newborn screening? action

Support

Support.

Support

Support.

  1. Which patient organisations and resources support families, according to health bodies? provenance
  2. Which entry fits rare disease support? action
Learn Research and teaching.

Research

Research.

Research

Research.

  1. What research on gene therapy and other treatments is under way, with findings attributed? provenance
  2. Which references are standard? provenance

Teach

Teaching.

Teach

Teaching.

  1. How can leukodystrophies be taught in neurology and genetics? action
  2. Which misconceptions arise? provenance

Classifiers Filled

Family
Thing Registry
Category
Cross-cutting context
Entry kind
thing
Plane
XCT
Domain
XCT.STA
Other names and narrower kinds
CADASIL, CADASIL 1, cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, RNASET2-deficient cystic leukoencephalopathy, adult-onset autosomal dominant demyelinating leukodystrophy, hypomyelinating leukodystrophy, megalencephalic leukoencephalopathy with subcortical cysts, leukoencephalopathy with vanishing white matter, RAVINE syndrome, Dermatoleukodystrophy, Leigh syndrome with leukodystrophy, Pelizaeus-Merzbacher-like disease

What it is Filled

A group of rare, mostly genetic disorders affecting the white matter of the brain and spinal cord through abnormal development, maintenance or loss of myelin, including hypomyelinating leukodystrophies, demyelinating forms such as metachromatic leukodystrophy and adrenoleukodystrophy, adult-onset forms, and related vascular white matter conditions such as CADASIL; leukodystrophies cause progressive neurological decline, are diagnosed by imaging and genetic testing, and are managed by specialist teams with some forms having specific treatments.

Why it exists Filled

Let an agent explain leukodystrophies and their types and genetic basis in general terms, relay diagnosis, management and support information from health bodies and patient organisations, and route personal medical questions to clinicians.

Distinguishing features Filled

  • White matter
  • Mostly genetic
  • Progressive
  • Rare

What robots and AI may and may not do Filled

Must not

  • Diagnose a leukodystrophy or interpret scans in place of a specialist.
  • Promote unproven therapies as cures.
  • Give prognosis to a family without a clinician.
  • Share a child's diagnosis or genetic results without consent.

Only with a human decision

  • Communicating a diagnosis or prognosis to a family.
  • Decisions about transplants or gene therapy.

May

  • Explain leukodystrophies and their main types in general terms.
  • Point families to specialist centres and patient organisations.

Moral aspects Filled

  • Leukodystrophies are often fatal in childhood; families face devastating news.
  • Newborn screening and treatments raise hard choices about timing and access.

Who is affected

  • Affected children and adults
  • Families and carers
  • Siblings at risk

Owners Filled

Steward

The patient; specialist clinicians and genetic services answer for care.

Master systems

  • Rare disease patient registries

Links to other meta-models Filled

parent

  • Q1620193 - registry parent class

related

  • cerebral degeneration - category
  • multiple sclerosis - an acquired demyelinating disease for contrast
  • mitochondrial disease - another group of rare genetic disorders
  • neurology - the specialty managing leukodystrophies

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.leukodystrophy
  • Wikidata: Q1821559 (https://www.wikidata.org/wiki/Q1821559)

Direct properties not applicable Not applicable

Not applicable

Plane XCT: no invented physical properties.

Recognition optional Filled

  • Disorders of brain white matter and myelin
  • Hypomyelinating, demyelinating, adult-onset, vascular
  • Multiple sclerosis is an acquired demyelinating disease, not a leukodystrophy
  • Not visible; seen on brain imaging.

Capabilities and actions required Filled

  • explain types and basis
  • relay diagnosis and management information
  • support families with resources
  • route personal questions

Hazards and failure modes required Filled

  • Agents giving personal diagnosis or treatment advice
  • Confusing with multiple sclerosis
  • Unproven treatments

Standards and interfaces required Filled

  • Clinical guidelines for leukodystrophies
  • Newborn screening for some forms
  • Genetic testing and counselling standards

Context of use required Filled

  • Genetic white matter disorders.
  • hypomyelinating leukodystrophies
  • lysosomal and peroxisomal leukodystrophies
  • adult-onset leukodystrophies
  • vascular leukoencephalopathies such as CADASIL
  • other rare white matter disorders

Sources Filled

  1. Wikidata item Q1821559: leukodystrophy - identity and sense of the item
  2. Wikipedia: Leukodystrophy - general description of the item

Open questions

  • Should specific leukodystrophies be separate entries?
  • How should patient organisations be linked?
  • How should research registries be linked?

Machine files

Card as JSON Specification Card backlog vercy.card/1

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q1821559/spec.json